PASW.US Ping An Biomedical Co., Ltd.
- Market cap
- USD 4.32M
- P/E
- -
- P/B
- 0.38x
- ROE
- 12.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Mar 2026.
Is PASW.US undervalued?
Graham numberThe Graham number of Ping An Biomedical Co., Ltd. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ping An Biomedical Co., Ltd. fundamental analysis
No fundamental analysis for Ping An Biomedical Co., Ltd. yet.
Ping An Biomedical Co., Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ping An Biomedical Co., Ltd.
Ping An Biomedical Co., Ltd., through its subsidiaries, provides supply chain management services in the apparel industry in China, Hong Kong, Cambodia, and Europe. The company offers market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. It also engages in the manufacturing and trading of yarns, textiles, and finished garments; real estate property investment; and warehousing services. The comp…
Full company profilePing An Biomedical Co., Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Mar 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Ping An Biomedical Co., Ltd. annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 99.5M | 115M | 82.6M | 87.6M | 34.1M | 19.2M |
| Gross Profit | 14.3M | 14.1M | 4.24M | 5.42M | 950K | 1.45M |
| Operating Income | 8.27M | 10.8M | 612K | -2.04K | -14.7M | 1.08M |
| EBITDA | 9.57M | 11.2M | 1.81M | 32.8K | -14.4M | 1.08M |
| Net Income | 5.21M | 7.23M | -994K | -1.28M | -12.8M | 9.65M |
| EPS | 0.38 | 14 | -1.94 | -2.85 | -28 | 7.64 |
| Balance Sheet | ||||||
| Total Assets | 73.7M | 81.9M | 79.8M | 56.8M | 68.4M | 100M |
| Total Liabilities | 75.8M | 77.3M | 85.7M | 64.0M | 23.2M | 22.0M |
| Shareholders' Equity | -2.06M | 4.60M | -5.86M | -7.19M | 45.2M | 78.2M |
| Cash & Short-term Investments | 106K | 1.17M | 592K | 131K | 1.17M | 6.84M |
| Total Debt | 29.0M | 35.6M | 43.0M | 10.8M | 10.5M | 10.3M |
| Cash Flow | ||||||
| Operating Cash Flow | -31.4M | 21.1M | -6.08M | 14.6M | -6.43M | 2.27M |
| Capital Expenditure | 27.0K | 24.8K | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -31.4M | 21.1M | -6.08M | 14.6M | -6.43M | 2.27M |
| Ratios | ||||||
| ROE | - | 157.1% | - | - | -28.4% | 12.3% |
| ROA | 7.1% | 8.8% | -1.2% | -2.3% | -18.8% | 9.6% |
| Net Profit Margin | 5.2% | 6.3% | -1.2% | -1.5% | -37.6% | 50.3% |
| Debt to Equity | - | 7.73x | - | - | 0.23x | 0.13x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Ping An Biomedical Co., Ltd. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | CNY 322K | 0.72 | - |
| 2023 | CNY 9.60M | 19 | - |
| 2022 | CNY 4.83M | 9.42 | 66.8% |
| 2021 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:40 on Oct 23, 2026.
Who owns Ping An Biomedical Co., Ltd.
- Insiders 12.06%
- Institutions 0.33%
- Public & others 87.61%
- Shares outstanding 2.82M
- Free float 1.87M
Top funds holding PASW.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Fidelity Nasdaq Composite Index | 5.76K | 0.00% | 0.00% | May 2026 |
Top institutions holding PASW.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| XTX Topco Ltd | 135K | 0.11% | -1.37% | Jun 2026 |
| Citadel Advisors Llc | 114K | 0.09% | 0.00% | Jun 2026 |
| Virtu Financial LLC | 37.0K | 0.03% | 0.00% | Jun 2026 |
| TWO SIGMA SECURITIES, LLC | 13.1K | 0.01% | -60.64% | Jun 2026 |
| Jane Street Group LLC | 0.00 | 0.00% | -100.00% | Jun 2026 |
| UBS Group AG | 0.00 | 0.00% | -100.00% | Jun 2026 |
Ping An Biomedical Co., Ltd. company profile
- Company name
- Ping An Biomedical Co., Ltd.
- Ticker
- PASW.US
- ISIN
- KYG5880S1131
- Exchange
- USA Stocks
- Listed since
- Jul 18, 2025
- Sector
- Consumer Cyclical
- Industry
- Distributors
- Employees
- 7
- Fiscal year end
- September
- Address
- China United Plaza, Cheung Sha Wan, Hong Kong
- Phone
- 852 3915 2600
- Website
- newbrandcashmere.com
About Ping An Biomedical Co., Ltd.
Ping An Biomedical Co., Ltd., through its subsidiaries, provides supply chain management services in the apparel industry in China, Hong Kong, Cambodia, and Europe. The company offers market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. It also engages in the manufacturing and trading of yarns, textiles, and finished garments; real estate property investment; and warehousing services. The company serves brand owners, textile manufacturers, apparel sourcing agents, and online fashion and garment retailers. It was formerly known as Majestic Ideal Holdings Ltd. and changed its name to Ping An Biomedical Co., Ltd. in September 2025. The company was founded in 2013 and is based in Cheung Sha Wan, Hong Kong. Ping An Biomedical Co., Ltd. operates as a subsidiary of Action Holdings Limited.
Ping An Biomedical Co., Ltd. management
3- Mr. Pijun LiuCEO & Executive Chairman · born 1982
- Mr. Sek Yan KoCo-Founder & GM · born 1960
- Ms. Hongli YangChief Financial Officer · born 1995